E. Rapsomaniki

First name
E.
Last name
Rapsomaniki
Attar-Zadeh, D. ., Capstick, T. ., Leese, D. ., Arnetorp, S. ., Rapsomaniki, E. ., Da Costa, K. P., … Quint, J. K. (2023). Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study. BJGP Open. http://doi.org/10.3399/bjgpo.2023.0015
Rapsomaniki, E. ., Shah, A. ., Perel, P. ., Denaxas, S. ., George, J. ., Nicholas, O. ., … Hemingway, H. . (2014). Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J, 35, 844–52. http://doi.org/10.1093/eurheartj/eht533
Rapsomaniki, E. ., Thuresson, M. ., Yang, E. ., Blin, P. ., Hunt, P. ., Chung, S. C., … Hemingway, H. . (2016). Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction. Eur Heart J Qual Care Clin Outcomes. http://doi.org/10.1093/ehjqcco/qcw004
Daskalopoulou, M. ., George, J. ., Walters, K. ., Osborn, D. P., Batty, G. D., Stogiannis, D. ., … Hemingway, H. . (2016). Depression as a Risk Factor for the Initial Presentation of Twelve Cardiac, Cerebrovascular, and Peripheral Arterial Diseases: Data Linkage Study of 1.9 Million Women and Men. PLoS One. http://doi.org/10.1371/journal.pone.0153838